Preventing heart attack and death in patients with coronary disease.

A randomized controlled trial evaluating the impact of knowledge translation and exchange strategies. Implement Sci (2009) 2.62

Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J (2004) 1.39

Using a summary measure for multiple quality indicators in primary care: the Summary QUality InDex (SQUID). Implement Sci (2007) 1.38

Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med (1997) 1.30

Characteristics of hypertensive Canadians not receiving drug therapy. Can J Cardiol (2008) 1.16

Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol (2003) 1.15

Cardiac assessment of veteran endurance athletes: a 12 year follow up study. Br J Sports Med (1999) 0.95

Cardiorespiratory fitness and risk of disability pension: a prospective population based study in Finnish men. Occup Environ Med (2003) 0.86

Disparities in combination drug therapy use in older adults with coronary heart disease: a cross-sectional time-series in a nationally representative US sample. Drugs Aging (2010) 0.81

Impact of Framingham risk score, flow-mediated dilation, pulse wave velocity, and biomarkers for cardiovascular events in stable angina. J Korean Med Sci (2014) 0.77

Primary and secondary prevention of heart disease: can we curb the global epidemic? Trans Am Clin Climatol Assoc (2001) 0.76

Effect of left ventricular hypertrophy on long-term survival of patients with coronary artery disease following percutaneous coronary intervention. Heart Int (2009) 0.75

Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke? Can Fam Physician (2000) 0.75

The effect of ethnicity on outcomes in a practice-based trial to improve cardiovascular disease prevention. Int J Equity Health (2004) 0.75

Effect of Silybin on Lipid Profile in Hypercholesterolaemic Rats. J Clin Diagn Res (2016) 0.75

A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data. Curr Control Trials Cardiovasc Med (2002) 0.75

Rehabilitation and secondary prevention in patients with cardiovascular diseases. Ital J Neurol Sci (1998) 0.75

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA (1995) 38.40

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA (1998) 19.64

The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med (1999) 17.75

Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65

Myb-related Schizosaccharomyces pombe cdc5p is structurally and functionally conserved in eukaryotes. Mol Cell Biol (1998) 10.34

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation (1995) 8.19

Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med (1999) 8.14

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04

Coronary plaque disruption. Circulation (1995) 8.04

Physical activity assessment methodology in the Five-City Project. Am J Epidemiol (1985) 7.90

Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA (1999) 7.88

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84

Idiopathic dilated cardiomyopathy. N Engl J Med (1994) 7.74

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51

Intensive lifestyle changes for reversal of coronary heart disease. JAMA (1998) 6.53

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet (1990) 6.49

Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol (1985) 6.10

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA (1999) 5.68

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62

Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med (2000) 5.58

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ (2009) 5.14

Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 5.08

Tyr527 is phosphorylated in pp60c-src: implications for regulation. Science (1986) 4.99

Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA (1999) 4.90

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol (2001) 4.89

Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med (1990) 4.70

Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr (1999) 4.64

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med (1993) 4.56

Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care (1990) 4.49

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41

Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation (1989) 4.32

Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med (1997) 4.27

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation (2001) 4.24

How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev (2003) 4.03

Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol (1978) 3.90

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA (2001) 3.90

Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med (1993) 3.90

Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med (1998) 3.89

Racial differences in the outcome of left ventricular dysfunction. N Engl J Med (1999) 3.85

Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med (1981) 3.85

Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol (2001) 3.83

Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med (2000) 3.66

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol (2001) 3.65

Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA (2000) 3.65

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol (2000) 3.54

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 3.49

Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest (1995) 3.44

A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43

Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation (1996) 3.41

Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol (1974) 3.39

The public health burdens of sedentary living habits: theoretical but realistic estimates. Med Sci Sports Exerc (1994) 3.38

Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem (1986) 3.37

Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation (1996) 3.34

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J (2001) 3.34

Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg (2000) 3.33

Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA (1994) 3.30

Restrictive cardiomyopathy. N Engl J Med (1997) 3.29

ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol (2001) 3.23

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation (1998) 3.18

The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med (1987) 3.17

Serum cholesterol. Doing the right thing. Circulation (1993) 3.16

Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation (1984) 3.15

Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med (2000) 3.14

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation (2001) 3.13

Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc (1993) 3.10

Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10

Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation (2000) 3.02

Does childhood personality predict longevity? J Pers Soc Psychol (1993) 2.95

Cholesterol and coronary heart disease. A new era. JAMA (1986) 2.95

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94

Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation (2001) 2.93

Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA (1984) 2.90

The Schizosaccharomyces pombe cdc3+ gene encodes a profilin essential for cytokinesis. J Cell Biol (1994) 2.90

Role of polo kinase and Mid1p in determining the site of cell division in fission yeast. J Cell Biol (1998) 2.89

The prevalence of peripheral arterial disease in a defined population. Circulation (1985) 2.88

Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med (1988) 2.84

Comparisons of leisure-time physical activity and cardiorespiratory fitness as predictors of all-cause mortality in men and women. Br J Sports Med (2010) 2.84

AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (2001) 2.79

Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med (1978) 2.78

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77

Physical activity behavior change: issues in adoption and maintenance. Health Psychol (2000) 2.75

A comparative evaluation of three accelerometry-based physical activity monitors. Med Sci Sports Exerc (2000) 2.75